scPharmaceuticals

SCPH · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

Reported earnings about 2 months ago

Total Revenue

$16M

Previous year: $8.05M

+99.2%

EPS

-$0.34

Previous year: -$0.44

-22.7%

FUROSCIX Doses Filled

20.2K

Previous year: 9.3K

+117.2%

Gross-to-Net Discount

27%

Unique FUROSCIX Prescribers

4.7K

Cash and Equivalents

$40.8M

Previous year: $38.5M

+6.0%

Total Assets

$80.3M

Previous year: $65.5M

+22.6%

Loading...

scPharmaceuticals

Unlock previous datapoints

Upgrade

scPharmaceuticals

Unlock previous datapoints

Upgrade

scPharmaceuticals Revenue by Segment

Revenue by Segment

FUROSCIX Revenue

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$293M

P/E Ratio

-3.12

Sector

N/A

Industry

N/A

52-Week High

$5.82

52-Week Low

$2.01

FUROSCIX Doses Filled

20.2K

Gross-to-Net Discount

27%

Unique FUROSCIX Prescribers

4.7K

Shares Outstanding

53.29M

Products

Get in Touch

Resources

scPharmaceuticals

scPharmaceuticals

scPharmaceuticals

scPharmaceuticals Revenue by Segment

Revenue by Segment

FUROSCIX Revenue

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics